Direct reprogramming of somatic cells into induced pluripotent stem (iPS) cells can be achieved by overexpression of Oct4, Sox2, Klf4 and c-Myc transcription factors, but only a minority of donor somatic cells can be reprogrammed to pluripotency.
Direct reprogramming of somatic cells into induced pluripotent stem (iPS) cells can be achieved by overexpression of Oct4, Sox2, Klf4 and c-Myc transcription factors, but only a minority of donor somatic cells can be reprogrammed to pluripotency.
Here we demonstrate that reprogramming by these transcription factors is a continuous stochastic process where almost all mouse donor cells eventually give rise to iPS cells on continued growth and transcription factor expression. Additional inhibition of the p53/p21 pathway or overexpression of Lin28 increased the cell division rate and resulted in an accelerated kinetics of iPS cell formation that was directly proportional to the increase in cell proliferation. In contrast, Nanog overexpression accelerated reprogramming in a predominantly cell-division-rate-independent manner. Quantitative analyses define distinct cell-division-rate-dependent and -independent modes for accelerating the stochastic course of reprogramming, and suggest that the number of cell divisions is a key parameter driving epigenetic reprogramming to pluripotency.
Quantifying the efficiency and timescales of crucial events occurring during in vitro reprogramming to pluripotency [1] [2] [3] [4] [5] has been problematic due to the cellular and genetic heterogeneity of de novo infected somatic cells 6, 7 . To circumvent the need for virus-mediated transduction and reduce the heterogeneity of reprogramming factor expression, a 'secondary' reprogramming transgenic system was devised where all somatic cells carry the same integration pattern of drug-inducible Oct4, Sox2, Klf4 and c-Myc viral transgenes [8] [9] [10] [11] . Although reprogramming of somatic cells from secondary mice was two orders of magnitude higher than in freshly infected somatic cells, only 1-20% of the induced cells generated iPS cells after 3-4 weeks of factor expression [9] [10] [11] [12] [13] . Furthermore, partially reprogrammed 'intermediate' cell lines have been derived in different experimental settings, some of which can give rise much later to fully reprogrammed iPS cells either spontaneously or upon additional manipulations 14, 15 . Given that the timescale of several weeks and relatively low efficiencies persist even after controlling for adequate Oct4, Sox2, Klf4 and c-Myc transgene expression, these studies left important questions relevant to the basic mechanisms of epigenetic reprogramming unresolved: how does the reprogramming process progress over time and what happens to the majority of the cells that do not become reprogrammed upon continued cell growth and expression of the reprogramming factors? Why do some somatic cells that circumvent senescence or apoptosis induced by Oct4, Sox2, Klf4 and c-Myc convert into iPS cells earlier than others? Do all adult donor cells expressing Oct4, Sox2, Klf4 and c-Myc reprogramming factors eventually give rise to iPS cells or would this be achieved only upon additional genetic or small molecule manipulation? Is high reprogramming efficiency restricted to non-lineage committed or adult stem cells 6,7,13,16,17 ? Models to account for the reprogramming process fall into two categories (models i-iv in Fig. 1 ). 'Deterministic' models posit that either 'all' (model i) or only a subset of 'elite' or 'stem-like' cells (model ii) within a donor population have the potential to generate iPS cells and are reprogrammed with a fixed latency. We define latency as the absolute time or the number of cell divisions that an individual donor cell undergoes until it gives rise to a daughter iPS cell. 'Stochastic' models posit that most if not all (model iii) or only a subset of 'elite' somatic cells (model iv) within a donor population have the potential to generate iPS cells, albeit with different latencies.
*These authors contributed equally to this work. 1 The Whitehead Institute for Biomedical Research, 2 Department of Physics, 3 To gain insight into the mechanism of reprogramming and to address some of these questions, we have characterized the reprogramming efficiency and kinetics of over 1,000 somatic-cell-derived monoclonal populations expressing Oct4, Sox2, Klf4 and c-Myc over an extended period of time and quantitatively defined distinct modes for changing the course of the reprogramming process upon additional genetic perturbations.
Reprogramming of monoclonal populations
We followed the reprogramming of individual somatic donor cells and studied their potential to generate iPS cells. Unlike fibroblasts, B-cell lineage-committed cells at the early pre-B-cell stage can be efficiently cloned as single cells immediately after isolation and were used as a defined, homogenous starting cell population for reprogramming into iPS cells. The NGFP1 iPS cell line was generated by infecting fibroblasts from Nanog-GFP reporter mice with doxycycline-inducible lentiviral vectors encoding the Oct4, Sox2, Klf4 and c-Myc transcription factors and injected into host blastocysts to generate secondary chimaeras 9, 18, 19 ( Fig. 2a ). NGFP1-derived secondary pre-B cells were single-cell sorted into individual wells and exhibited high cloning efficiency on doxycycline (.80%). Populations were serially passaged and monitored weekly for reactivation of the endogenous Nanog-GFP knock-in reporter ( Supplementary Fig. 1 ), which represents one of the final events during reprogramming 4, [20] [21] [22] . We defined reprogramming efficiency as the long-term potential of a cell to generate iPS daughter cells. A detection value of .0.5% for Nanog-GFP 1 cells per well reproducibly allowed for stable derivation of Nanog-GFP 1 iPS cells upon doxycycline withdrawal ( Supplementary Fig. 2 ), and was set as the minimal threshold for defining positive detection of iPS cells in clonal populations. Nanog-GFP 1 cells were detected after 2 weeks of doxycycline induction, with ,3-5% of the wells generating Nanog-GFP 1 cells at 2 weeks [10] [11] [12] (Fig. 2b ). The remaining wells contained viable cells, could be propagated in the presence of doxycycline, and uniformly silenced somatic/haematopoietic surface markers 15, 22 ( Supplementary  Fig. 3 ). Upon extended culture, the fraction of wells with iPS cells gradually increased and by 18 weeks after doxycycline addition .92% of the wells had produced Nanog-GFP 1 cells ( Fig. 2b) , demonstrating that most if not all donor cells have the potential to generate iPS cells. The reprogramming kinetics were reproducible in independent experiments ( Fig. 2b ) and were not restricted to B cells, as CD11b 1 monocytes that showed comparable transgene induction levels generated iPS cells with similar kinetics and efficiency ( Supplementary Fig. 4 ). Nanog-GFP 1 cell populations selected at random gave rise to stable doxycycline-independent iPS cell lines. Furthermore, all tested iPS cell lines had normal karyotypes and generated teratomas and chimaeras irrespective of whether they were derived at early or late time points during the process ( Fig. 2c and Supplementary Fig. 5 ). The iPS cell lines carried distinct genetic heavy-chain rearrangements verifying their independent clonal origin ( Fig. 2d ). We assessed whether transgene expression levels or increased proliferation rate could underlie the well-to-well differences seen in the latency of reprogramming. The population-averaged cell doubling times (t d ) and transgene induction levels during the reprogramming process were similar in NGFP1 clonal populations irrespective of time on doxycycline or whether these populations contained a Nanog-GFP 1 fraction ( Fig. 2e , f). These results suggest the following: (1) reprogramming of somatic cells is a continuous stochastic process where nearly all somatic donor cells have the ability to give rise to iPS cells upon continuous passaging and expression of Oct4, Sox2, Klf4 and c-Myc. (2) Although reprogrammed cells do not appear before 8-10 days of Oct4, Sox2, Klf4 and c-Myc expression 21, 22 , the time of doxycycline exposure or number of cell divisions achieved before a given clonal population generates iPS cells varies widely. (3) Our data are not consistent with an 'elite component' in reprogramming, as most if not all lineagecommitted B cells or monocytes are able to generate iPS cells rather than only a small fraction of putative somatic stem cells present in the donor cell population 7, 12, 13 . (4) Finally, somatic cells reprogram with different latencies that cannot be predicted on the basis of time of doxycycline exposure or proliferation rate, consistent with undefined stochastic events driving the process (model iii in Fig. 1 ).
Cell division rate and reprogramming
We next characterized parameters of the reprogramming process by introducing defined genetic perturbations. Recently, p53 (also called Trp53) inhibition has been shown to enhance the efficiency of iPS cell formation from fibroblasts by direct viral infection or transient transfection protocols by reducing apoptosis after initial transgene induction 16, [23] [24] [25] [26] [27] . We tested whether and how p53 inhibition would influence the reprogramming of secondary transgenic NGFP1 iPS-cell-derived pre-B cells that have a high single-cell cloning efficiency and stably grow in the presence of doxycycline without requiring additional immortalization and with only background apoptosis levels ( Supplementary  Fig. 6 ). NGFP1 iPS cells were infected with a constitutively expressed lentiviral vector encoding a short interfering RNA (siRNA) hairpin for p53 ( Supplementary Fig. 7 ) 28 . Infected cells were injected into host blastocysts and NGFP1-p53 knockdown (p53 KD ) B cells were singlecell sorted and cultured in doxycycline. p53 inhibition did not alter transgene expression levels or affect the already residual levels of apoptosis ( Fig. 3a and Supplementary Figs 6 and 8 ), but rather shortened the cell-population-averaged doubling time of p53 KD cells in the presence of doxycycline by ,2-fold as compared to control NGFP1derived cells ( Fig. 3b and Supplementary Fig. 9 ). The kinetics of iPS cell formation proceeded with a significantly accelerated rate, with 93% of the wells producing Nanog-GFP 1 cells within 8 weeks of doxycycline, as compared to 17 weeks for the control cells (Fig. 3c ). The iPS cell lines were doxycycline independent, expressed pluripotency markers and generated teratomas and mouse chimaeras ( Supplementary Fig. 10 ).
To assess whether the enhanced reprogramming could be attributed to the effect of p53 inhibition on proliferation rate, we estimated, based on the population-averaged doubling times measured throughout the process, how many cell divisions have occurred for each NGFP1 and NGFP1-p53 KD clonal population during the latency period. Upon rescaling of latency by the doubling time ( Fig. 3c, d) , the cumulative fraction of wells generating iPS cells collapsed to the same statistically significant distribution with cell division number for both the NGFP1 and NGFP1-p53 KD wells (log-rank test for dissimilarity, P 5 0.518). A similar analysis on NGFP1 and NGFP1-p53 KD CD11b 1 cell-derived clonal populations showed a comparable distribution (log-rank test for dissimilarity, P 5 0.209; Supplementary Fig. 11 ). Latencies were not normally distributed about the mean latency, but rather were better fit with a gamma distribution ( Supplementary Figs 12 and 13 ). Knockdown of the p21 gene, a downstream effector of p53 which regulates cell-cycle progression 29 , recapitulated the change in cell division rate and acceleration of reprogramming dynamics upon Oct4, Sox2, Klf4 and c-Myc expression ( Fig. 3a-d and Supplementary Figs 6-9 and 14) , further substantiating that change in cell division rate directly rescales the kinetics of reprogramming to distributions similar to Oct4, Sox2, Klf4 and c-Myc alone. Finally, we studied the effect of Lin28 overexpression on the reprogramming dynamics, as it enhances the reprogramming of human fibroblasts and acts as an oncogene by modulating the expression of cell-cycle regulators 5, 30 . NGFP1-Lin28 OE (Lin28 overexpresser)-derived B-cell populations demonstrated accelerated reprogramming kinetics that directly correlated with the observed increase in cell division rate on doxycycline (P 5 0.327; Fig. 3a-d) . In summary, our data demonstrate that both p53/p21 Exponential growth (dashed line) described the data well (R 2 5 0.97-1.0), and the population-averaged doubling times (t d ) were calculated from these fits ( Supplementary Fig. 9 ). c, As in Fig. 2b , latencies for reprogramming various clonal B-cell-derived populations. NGFP1-p53 KD , NGFP1-p21 KD and NGFP1-Lin28 OE wells were statistically distinct from the NGFP1 and NGFP1-control hairpin wells (P , 0.0001, log-rank test for dissimilarity). inhibition or Lin28 overexpression accelerate the reprogramming process rather than enhancing overall efficiency, as the cells divide more rapidly, resulting in an increased cumulative probability for the stochastic events to occur earlier in time ( Fig. 3a-d) .
Cell-division-rate-independent acceleration
We investigated whether reprogramming could be accelerated by mechanisms that are independent of cell proliferation rate. Nanog is a pluripotency factor expressed in the inner cell mass, and deriving embryonic stem cells and iPS cells requires the presence of functional endogenous Nanog alleles 31 . Moreover, Nanog enhances the transfer of pluripotency by cell fusion and facilitates direct reprogramming of human cells 5, [32] [33] [34] [35] . Therefore, we aimed to investigate the effect of additional ectopic Nanog expression on the reprogramming kinetics by Oct4, Sox2, Klf4 and c-Myc proteins. B cells were derived from an NGFP1-Nanog OE (Nanog overexpresser) iPS cell line carrying a doxycycline-inducible Nanog-encoding transgene ( Supplementary  Fig. 7) . The presence of the transgene did not alter the expression of Oct4, Sox2, Klf4 and c-Myc (Fig. 3a ). Overall efficiency of iPS cell formation was similar to that of the control cells but reprogramming occurred with a significantly accelerated kinetics, with 94% of the wells producing pluripotent Nanog-GFP 1 cells within 8 weeks of doxycycline ( Fig. 3e and Supplementary Figs 15 and 16 ). Nanog overexpression slightly increased the cell-population-averaged doubling time of doxycycline-induced NGFP1-Nanog OE cells compared to control NGFP1-derived reprogramming cells (Fig. 3b) 36, 37 . However, even after rescaling time on doxycycline by the change in doubling time (Fig. 3f) , the cumulative fraction of wells generating iPS cells did not collapse to the same distribution with cell division number (log-rank test for dissimilarity, P , 0.0001). The median number of cell division divisions before wells produced iPS cells was significantly reduced from about 70 cell divisions in the NGFP1, NGFP1-p21 KD and NGFP1-p53 KD wells to 50 cell divisions in the NGFP1-Nanog OE wells (Fig. 3d, f and Supplementary Fig. 12d ). These results suggest that Nanog overexpression accelerates the reprogramming kinetics by cell-intrinsic mechanisms that are independent of an altered cell proliferation rate.
Numerical modelling of reprogramming
We used our data sets to conduct simulations of the stochastic reprogramming process occurring in individual cells. To assess the intrinsic rate of reprogramming per cell, we tested whether a simple stochastic model would describe our observations. The model considers the reprogramming of B cells to occur as a one-step process with a constant cell-intrinsic rate k (Fig. 4a ). Because iPS cells were adherent and selectively retained throughout the culturing procedures, the latency measured for each well was representative of the timing at which the first B cell in the population reprogrammed plus a time delay, t p , during which the daughter cells needed to grow to reach the detection threshold. At any given time t, the number of cells in each well, N(t), scales the rate at which the first reprogramming event takes place, and the cumulative probability distribution of reprogramming times is P(t 1 t p ) < 1 2 e 2kt , where t is the 'populationrescaled time', . Interpreting the experimental results in terms of this rescaled version of time allowed one to separate the contributions of population size and cell-intrinsic reprogramming rate ( Fig. 4) . Cell division rate can control the population size, N, and thus re-scales time, affecting the observed rate of reprogramming. For example, if the cell division rate and culturing procedures were modified to an effective population size of 1,000 cells in each well rather than ,10 6 cells per well (Fig. 4b, c) , longer times would have been necessary to reach .90% reprogrammed wells. summary. Sequential re-plating of individual wells during each experiment establishes that, after a time t 0 representative of the time at which the replatings started, each experiment can be described in terms of a population of an effective size, N eff . b, Estimate of the population rescaled time, t, throughout each experiment. After t 0 , population dynamics are effectively described by a fixed population of size, N eff . NGFP1-p53 KD and NGFP1-p21 KD have similar dynamics. c, N eff and the population-rescaled average proliferation times, t p , estimated as the population-rescaled time necessary for one iPS cell to reach the detection threshold (t p 5 t d,i N eff log 2 (rN eff ), where r is the detection threshold and t d,i is the doubling time of iPS cells). d, Cumulative percentage of Nanog-GFP 1 wells as a function of t, and best fits according to the proposed model. Modelling results are shown as thick lines; experiments are shown as dots. The far-right graph indicates best-fit estimates of the cell-intrinsic rate k expressed in terms of weeks. e, As in d, but per population-rescaled cell divisions, t/t d , instead of per t units. t d is the doubling time of the populations. Error bars indicate 95% confidence intervals.
Using cell population dynamics to account for the growth and culturing procedures used across the different NGFP1 lines (Fig. 4b, c) , we calculated the population-rescaled time and fit the cell-intrinsic rate k using a likelihood maximization approach (Fig. 4d, e and Supplementary Fig. 17 ). Reasonable agreement was seen between best fits and the experiments. Furthermore, to take into account fluctuations in cell division times, number of cells and potential loss of iPS cells during culturing, in addition to the stochasticity in the cell-intrinsic reprogramming process, we implemented a detailed computer simulation of each experiment ( Supplementary Fig. 18 ). Simulation results were consistent with those achieved using the analytical approach (Fig. 4d, e ). The inferred intrinsic reprogramming rates per cell division for NGFP1-p53 KD and NGFP1-p21 KD cells were similar to NGFP1 cells ( Fig. 4e and Supplementary Figs 17 and 18 ), suggesting that p53/p21 pathway inhibition in our system accelerates reprogramming through a predominately cell-division-rate-dependent mechanism. The slightly higher cell-intrinsic rates in some of our modelling results for p53/p21 inhibition (Fig. 4d, e and Supplementary Figs 17  and 18 ) may reflect a modest acceleration due to cell-division-rateindependent mechanisms and we cannot exclude that inhibition of the p53/p21 pathway slightly enhances reprogramming by additional mechanisms as well as in different experimental systems. The acceleration observed for NGFP1-Lin28 OE cells occurred predominantly because of a larger effective population size resulting from a faster cell division rate on doxycycline when following a culturing procedure similar to that used for NGFP1 cells (Fig. 4b, c) . Only in the case of NGFP1-Nanog OE cells, higher than 1.75-2 fold intrinsic reprogramming rates per cell division compared to NGFP1 cells was robustly obtained in all modelling approaches ( Fig. 4e and Supplementary  Figs 17 and 18) , supporting the hypothesis that Nanog overexpression accelerates reprogramming through a predominately cell-divisionrate-independent mechanism. Future characterization of how Nanog molecularly orchestrates the re-establishment of the core pluripotency circuitry is of great interest.
Discussion
We used a highly defined quantitative system for analysing the reprogramming process and suggest that yet-to-be-defined rate-limiting stochastic events occur as a function of cell division before the fully reprogrammed pluripotent state is attained. Upon Oct4, Sox2, Klf4 and c-Myc induction in our system, most, if not all, monocytes and lineage-committed B cells harbouring genetic rearrangements have the potential to generate iPS cells, albeit with very different latencies (model iii, Fig. 1 ). These results are inconsistent with models in which iPS cells preferentially arise from a particular epigenetic state in the donor cell population, such as a progenitor or an adult stem cell (models ii and iv, Fig. 1 ). The dynamics of direct in vitro reprogramming to pluripotency by Oct4, Sox2, Klf4 and c-Myc are consistent with a continuous stochastic process, in which the conversion from a somatic cell to an iPS cell can be thought of as a drift in cell state. This cell state can be defined by a gene expression or epigenetic pattern, the fluctuations of which drive the conversion to an iPS cell. These fluctuations are probably due to cell-to-cell extrinsic heterogeneity or the inherent stochastic nature of gene expression or regulatory signalling processes [38] [39] [40] . In the simplest scenario, the process could be modelled as a one-step rate-limiting transition characterized by a cell-intrinsic rate, and we found that this model describes reasonably the observed dynamics across all of the different cell lines. Our model relies on inferring a single cell-intrinsic rate averaged over the entire course of reprogramming, although the model does not optimally describe the reprogramming behaviour at early times after transgene induction (Fig. 4 ). This deviation between modelling and experimental results may indicate that the cell-intrinsic rate changes over the course of reprogramming within clonal populations. Intraclonal monitoring of reprogramming dynamics at various points throughout the process could be used to add further mechanistic detail to the model, and to decipher the identity and sequence of rate-limiting step(s) and epigenetic changes that occur during reprogramming.
Quantitative analysis of the differences in reprogramming latency upon different genetic perturbations defined two distinct modes of accelerating the reprogramming process ( Fig. 5 and Supplementary  Fig. 19 ). In the 'cell-division-rate-dependent' mode, the cumulative probability for successful reprogramming is higher and can be achieved earlier in time and directly proportional to the augmentation in cell division rate, whereas in the 'cell-division-rate-independent' mode, reprogramming acceleration occurs over a lower average number of cell divisions. Notably, the different modes need not be mutually exclusive as certain perturbations could enhance or inhibit reprogramming via both cell-proliferation-dependent and -independent effects. Recent studies failed to attain correlation between cell division rate and reprogramming efficiency; however, these studies relied on measuring proliferation in the absence of Oct4, Sox2, Klf4 and c-Myc transgenes 16 or by inducing proliferation with haematopoietic cytokines for which the receptors are rapidly silenced after transgene induction 13 . Our experimental and modelling data suggest that close monitoring of transgene induction, plating efficiency, cell proliferation and changes in population size throughout the experiments are needed to gain insight into the stochastic process of reprogramming. We consider two possibilities for the ability of increased cell division rate to accelerate and drive the kinetics of the reprogramming process: (1) cell division could amplify the number of daughter cells from partially reprogrammed cells where each resulting individual cell has an independent probability of progressing towards becoming an iPS cell; and (2) nuclear changes during cell division may facilitate the acquisition of epigenetic marks such as DNA and histone modifications that allow the re-establishment of the core transcriptional circuitry that stabilizes pluripotency 6, 15, 41, 42 . iPS cells can be derived by various combinations of transcription factors and/or small molecules 3, 5, 43, 44 . Our study identifies the average number of cell divisions required to give rise to an iPS cell at a particular efficiency as a key parameter that may be affected by different reprogramming strategies. After nuclear transfer, the pluripotency gene Oct4 (also called Pou5f1) of the somatic nucleus is reactivated in the cloned embryo within 1-2 cell divisions 42, 45, 46 (Fig. 5c ), indicating that the egg cytoplasm carries as-of-yet undefined determinants that accomplish robust reprogramming within very few cell divisions. These observations raise questions of whether direct reprogramming strategies devised so far can be robustly enhanced (for example, by optimizing stoichiometry, small molecule treatment or utilizing oocyte-derived transcript libraries) to enable complete in vitro reprogramming within only a few cell divisions.
METHODS SUMMARY
The NGFP1 iPS cell line was derived after culturing the infected mouse embryonic fibroblasts (MEFs) carrying ROSA26-M2rtTA mice and Nanog-GFP alleles with doxycycline-inducible lentiviruses encoding Oct4, Klf4, c-Myc and Sox2 cDNA driven by the TetO/CMV promoter 9 . To generate the different genetically perturbed NGFP1 subclones, 50,000 NGFP1 cells were infected with the pSicoR vector 28 encoding a hairpin for the p53 or p21 tumour suppressor genes or with doxycycline-inducible lentiviruses encoding Nanog or Lin28 cDNAs. To generate mouse chimaeras iPS cells were injected into diploid blastocysts that were initially harvested 94-98 h after hormone injection and placed in a drop of DMEM with 15% FCS under mineral oil. Pre-BCR 1 (Igm 1 IgK 2 IgL 2 ) early-pre B cells were single-cell sorted from 3-5-week-old chimaeras and were plated in gelatinized and irradiated OP9-coated wells with ES media supplemented with doxycycline (4 mg ml 21 ). IL-7 and SCF (10 ng ml 21 each, Peprotech) were supplemented to the media for the first 1-2 weeks to optimize cloning efficiency in the presence of doxycycline. After 2 weeks of doxycycline induction, cultures were trypsinized every week and passaged on gelatinized plates in ES cell medium plus doxycycline. Populations were defined positive for iPS cell generation when .0.5% of the 10,000 adherent/semi-adherent screened cells by FACS were GFP 1 . NGFP1-p53 KD and p21 KD derived cells were passaged twice a week (versus once a week at the time of GFP assays for the other groups) to avoid over-confluence in the culture wells due to their accelerated proliferation rate. The reprogramming experiments were stopped at different time points and all non-reprogrammed populations were viable and demonstrated robust growth on doxycycline upon ending each experiment. For teratoma generation, 2 3 10 6 iPS cells were injected subcutaneously into both flanks of recipient SCID mice, and tumours were harvested for sectioning 3-6 weeks after initial injection.
